Verastem, Inc. - Common Stock - balanço patrimonial (NASDAQ:VSTM)

Financials

Total de ativos 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Total de passivos 39.08 M21.1 M47.66 M71.19 M130.43 M189.25 M Capital total 115.27 M87.56 M47.39 M57.37 M-28.89 M57.2 M Total de passivos e patrimônio líquido 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Dívida total 19.05 M249 K24.8 M40.09 M40.72 M76.33 M Dívida líquida -128.45 M-100.05 M-63.1 M-97.04 M-48.08 M-128.67 M

Verastem, Inc. - Common Stock

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem, Inc. - Common Stock

Notícias

Verastem Oncology nomeia Michael Bailey para o conselho de administração

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/22/26 - TipRanks.com

Cancer Stocks That Are Advancing the Future of Oncology Care

Verastem (VSTM) Loses 34.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Verastem, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:VSTM) 2026-05-09

BTIG reduz preço-alvo da Verastem para US$ 18 após receita abaixo do esperado

Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates

Vectoring In On Verastem (NASDAQ:VSTM)

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

H.C. Wainwright reitera classificação de compra para Verastem com base em dados duráveis de ensaio clínico

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

Ações da Verastem mantêm recomendação de compra na BTIG após dados duráveis de estudo